Marsh & McLennan, US5717481023

Marsh & McLennan Stock - Analyst consensus and fresh fund interest

17.06.2026 - 20:37:54 | ad-hoc-news.de

Marsh & McLennan attracts new institutional money while consensus on the stock remains cautious. A look at recent filings, valuation and what analysts expect next for the insurance broker and consulting group.

Marsh & McLennan, US5717481023
Marsh & McLennan, US5717481023

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 20:35 CET. Details in the imprint.

Marsh & McLennan (US5717481023) stays on institutional investors' buy lists, as recent filings show fresh positions in the stock. Market data providers also highlight a cautious but stable analyst consensus on the group with a Hold rating and upside to target prices.

Go deeper

All news and analysis on Marsh & McLennan stock

Find more regulatory filings, analyst updates and background on Marsh & McLennan stock in our dedicated topic center.

Fresh institutional positions disclosed

Recent fund filings point to continued interest in Marsh & McLennan shares from institutional investors. One disclosure shows a new position of 20,000 shares worth about $3.71 million, established in the fourth quarter according to MarketBeat data.

Another filing reported that Polar Capital Holdings added a new stake, underlining that the stock remains a core holding candidate for active managers despite its defensive profile. These moves come as the company trades near the middle of its 12-month trading range.

What analysts currently expect

Consensus compiled by MarketBeat indicates that Marsh & McLennan stock is rated Hold overall, with an average analyst price target of about $200.19 per share. That implies upside from recent trading levels, but not an aggressive growth call.

The same data set shows a mix of Buy, Hold and Sell recommendations, reflecting a balanced view on valuation and growth prospects. Against this backdrop, investors face a classic quality-versus-price trade-off in a mature insurance brokerage and consulting business.

How the company makes money

Marsh & McLennan generates most of its revenue from risk and insurance services through Marsh and reinsurance broker Guy Carpenter, alongside consulting and human capital advisory work under Mercer and Oliver Wyman. The group focuses on corporate clients seeking risk management, benefits and strategy advice.

Where the stock trades today

Marsh & McLennan shares trade on the New York Stock Exchange under the ticker MMC at about $166.70 as of 06/17/2026, 20:00 CET, based on recent market data in USD.

Key facts on Marsh & McLennan stock

  • Company: Marsh & McLennan Companies, Inc.
  • ISIN: US5717481023
  • WKN: 858415
  • Ticker: MMC
  • Venue: NYSE
  • Price (as of 06/17/2026, 20:00 CET): 166.70 USD
  • Market cap: around 82,000,000,000 USD (as of 06/17/2026)
  • Sector / Industry: Financials / Insurance Brokers & Consulting
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on Marsh & McLennan stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US5717481023 | MARSH & MCLENNAN | boerse | 69565938 | bgmi